Final Quiz Condor

What is the primary mechanism of action of Vildagliptin in Jalra-OD?

• SGLT2 inhibition

• DPP-4 enzyme substrate blocking

• GLP-1 receptor agonism

• Insulin secretion stimulation

Jalra-OD is specifically recommended for T2DM patients uncontrolled on:

• Metformin monotherapy

• Sulfonylurea combinations

• Insulin therapy

• GLP-1 agonists

How does Jalra-OD compare to Teneligliptin in efficacy?

• Lower HbA1c reduction

• Better β-cell preservation

• Higher risk of hypoglycemia

• Requires twice-daily dosing

What additional benefit does Jalra-OD offer over Sitagliptin?

• 3 hours more Time in Range (TIR)

• Weight gain

• Increased glucagon secretion

• Higher cost

Which study demonstrated Jalra-OD's CV safety?

• DAPA-HF

• EDGE study

• UKPDS

• VERIFY trial

What is the composition of Jalra-DP?

• Vildagliptin + Dapagliflozin

• Metformin + Sitagliptin

• Glimepiride + Metformin

• Empagliflozin + Linagliptin

Which trial reported a 1.9% HbA1c reduction with Jalra-DP in 3 months?

• REFORM Study

• DA VINCI Study 2025

• DECLARE-TIMI

• EMPA-REG OUTCOME

Jalra-DP is indicated for T2DM patients with:

• HbA1c <7%

• CV risks and HbA1c >7%

• Type 1 diabetes

• Diabetic ketoacidosis

What is a key advantage of Jalra-DP’s low-dose variant (DP50)?

• Higher cost

• Affordability (Rs 12.5 per tablet)

• Increased hypoglycemia risk

• Once-weekly dosing

Which organ systems are targeted by Jalra-DP's dual mechanism?

• Pancreas and kidneys

• Liver and muscles

• Brain and adipose tissue

• Heart and lungs